Single use bioreactors for the clinical production of monoclonal antibodies – a study to analyze the performance of a CHO cell line and the quality of the produced monoclonal antibody
Main Authors: | Diekmann Sonja, Dürr Constanze, Herrmann Alexander, Lindner Ingo, Jozic Daniela |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | BMC Proceedings |
Similar Items
-
Correction: Analyzing Clonal Variation of Monoclonal Antibody-Producing CHO Cell Lines Using an Metabolomic Platform.
Published: (2014-01-01) -
Analyzing clonal variation of monoclonal antibody-producing CHO cell lines using an in silico metabolomic platform.
by: Atefeh Ghorbaniaghdam, et al.
Published: (2014-01-01) -
Correction: Analyzing Clonal Variation of Monoclonal Antibody-Producing CHO Cell Lines Using an In Silico Metabolomic Platform
by: The Staff
Published: (2014-01-01) -
Development of CHO DG44 stable cell lines producing a monoclonal antibody biosimilar
by: Wei-Siou Tseng, et al.
Published: (2017) -
Study of a recombinant CHO cell line producing a monoclonal antibody by ATF or TFF external filter perfusion in a WAVE Bioreactor™
by: Clincke Marie-Françoise, et al.
Published: (2011-11-01)